Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: A comprehensive analysis
2019
BACKGROUND: Data on the treatment of patients with hepatitis C virus (HCV)/human immunodeficiency virus (HIV) coinfection remains limited. A comprehensive analysis was performed to evaluate the efficacy and safety of...
Seroprevalence of HIV among pregnant women in Ethiopia: A systematic review and meta-analysis
2018
OBJECTIVE: This systematic review and meta-analysis aimed to determine the pooled prevalence of HIV among pregnant women in Ethiopia. RESULT: PubMed, EMBASE, Science Direct and Google scholar databases were searched...
Maternal immunisation to improve the health of HIV-exposed infants
2018
HIV-exposed but uninfected (HEU) infants are at an increased risk of many infectious diseases that can contribute to the high mortality seen among HEU children. Maternal immunisation could be a...
Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection – A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis
2018
BACKGROUND: Men who have sex with men (MSM) and who engage in condomless anal intercourse with casual partners are at high risk of acquiring sexually transmitted infections (STIs), but reliable...
Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature
2018
BACKGROUND: The Philippines is experiencing one of the fastest growing epidemics globally. Evidence-based public health policies are needed. To describe the public health literature on HIV risk groups and prevention...
Common conditions and diseases in HIV-positive men who have sex with men
2014
Key take-home messages HIV-positive men who have sex with men who experience many physical health conditions at significantly higher rates than their peers who are HIV-negative and the general population,...
Treatment barriers and best practices for newcomers living with HIV/HCV
2014
Key take-home messages Minority groups, including newcomers, are disproportionately affected by HIV and hepatitis C (HCV) due to social and economic factors that increase their vulnerability to infection. Newcomers living...
HCV reinfection rates among people who use drugs
2014
Key take-home messages HCV affects people differently. Some are able to spontaneously clear the virus on their own; others develop chronic HCV infection that affects their health and requires treatment....
Epidemiology of hepatitis C virus infection among men who have sex with men
2016
Key take-home messages HCV prevalence and incidence are low among HIV-negative men who have sex with men without a history of injection drug use and insufficient evidence exists to warrant...
Hepatitis C reinfection after successful treatment
2016
Key take-home messages HCV reinfection rates vary widely. Reinfection depends on the extent to which an individual engages in high risk activities after having achieved sustained virologic response through treatment....
Impact of successful hepatitis C treatment on quality of life
2016
Key take-home messages People living with HCV who receive treatment and achieve sustained virologic response (SVR) have better healthrelated quality of life scores than people who do not respond to...
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: A meta-analysis
2018
BACKGROUND: Currently, there is no consensus on the efficacy and safety of lamivudine (LAM) plus tenofovir disoproxil fumarate (TDF) combination therapy versus lamivudine monotherapy in HBV/HIV coinfected patients. METHODS: A...
